Physician profile
Kimberly I Box
NPI 1225119431
$950.45
in general payments reported to CMS, 2019-2025
11 companies · $78.42 in 2025
The $78.42 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $121 · 2023: $350 · 2024: $256 · 2025: $78.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $221.79 | 2021-2024 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $204.93 | 2021-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $166.65 | 2023-2024 | Belbuca, Xtampza |
| Azurity Pharmaceuticals, INC. | $83.43 | 2023-2024 | Horizant, Horizant |
| Arbor Pharmaceuticals, INC. | $73.42 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.64 | 2023 | Relistor |
| Valinor Pharma, LLC | $45.14 | 2025 | Movantik |
| Globus Medical, INC. | $33.28 | 2025 | Senza |
| Abbott Laboratories | $24.55 | 2024 | Octrode |
| Protega Pharmaceutials INC | $22.35 | 2024 | Roxybond |
| Ibsa Pharma INC. | $15.27 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Box listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.